These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22030684)

  • 1. [The cost-effectiveness of using magnetic resonance plus conventional radiography in diabetic-foot patients].
    Chicaíza-Becerra LA; Gamboa-Garay O; García-Molina M
    Rev Salud Publica (Bogota); 2010 Dec; 12(6):974-81. PubMed ID: 22030684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS, COMPARED WITH ON-DEMAND TREATMENT, FOR PATIENTS WITH SEVERE HEMOPHILIA TYPE A IN COLOMBIA.
    Castro Jaramillo HE; Moreno Viscaya M; Mejia AE
    Int J Technol Assess Health Care; 2016 Jan; 32(5):337-347. PubMed ID: 27919309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foot infections in diabetic patients. Decision and cost-effectiveness analyses.
    Eckman MH; Greenfield S; Mackey WC; Wong JB; Kaplan S; Sullivan L; Dukes K; Pauker SG
    JAMA; 1995 Mar; 273(9):712-20. PubMed ID: 7853629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
    de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
    Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes.
    Wen J; Jin X; Al Sayah F; Johnson JA; Paulden M; Ohinmaa A
    Can J Diabetes; 2022 Mar; 46(2):126-133. PubMed ID: 35148951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.
    Ortegon MM; Redekop WK; Niessen LW
    Diabetes Care; 2004 Apr; 27(4):901-7. PubMed ID: 15047646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease.
    McMahon PM; Araki SS; Neumann PJ; Harris GJ; Gazelle GS
    Radiology; 2000 Oct; 217(1):58-68. PubMed ID: 11012424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic foot and neuroarthropathy: magnetic resonance imaging evaluation.
    Yu JS
    Top Magn Reson Imaging; 1998 Oct; 9(5):295-310. PubMed ID: 9773970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of the diabetic foot. Emphasis on nuclear medicine and magnetic resonance imaging.
    Loredo R; Metter D
    Clin Podiatr Med Surg; 1997 Apr; 14(2):235-64. PubMed ID: 9135902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
    Wu B; Chen H; Shen J; Ye M
    Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
    Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
    Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.
    Moreno S; González J; Lekander I; Martí B; Oyagüez I; Sánchez-de la Rosa R; Casado MA
    Clin Ther; 2010 Dec; 32(13):2232-45. PubMed ID: 21316539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
    Viriato D; Calado F; Gruenberger JB; Ong SH; Carvalho D; Silva-Nunes J; Johal S; Viana R
    J Med Econ; 2014 Jul; 17(7):499-507. PubMed ID: 24708176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand.
    Chirakup S; Chaiyakunapruk N; Chaikledkeaw U; Pongcharoensuk P; Ongphiphadhanakul B; Roze S; Valentine WJ; Palmer AJ
    Value Health; 2008 Mar; 11 Suppl 1():S43-51. PubMed ID: 18387067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of expanded newborn screening in Texas.
    Tiwana SK; Rascati KL; Park H
    Value Health; 2012; 15(5):613-21. PubMed ID: 22867769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling cost-effectiveness of cervical cancer screening in Hungary.
    Vokó Z; Nagyjánosi L; Margitai B; Kövi R; Tóth Z; László D; Kaló Z
    Value Health; 2012 Jan; 15(1):39-45. PubMed ID: 22264970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based evaluation of diabetic foot prevention strategies in Austria.
    Rauner MS; Heidenberger K; Pesendorfer EM
    Health Care Manag Sci; 2005 Nov; 8(4):253-65. PubMed ID: 16379409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
    Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children.
    Castañeda-Orjuela C; Alvis-Guzmán N; Velandia-González M; De la Hoz-Restrepo F
    Vaccine; 2012 Mar; 30(11):1936-43. PubMed ID: 22266291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.